HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao Lin Selected Research

Migraine Disorders (Migraine)

1/2021Network Pharmacology and Metabolomics Studies on Antimigraine Mechanisms of Da Chuan Xiong Fang (DCXF).
1/2020Progress in Traditional Chinese Medicine for the Treatment of Migraine.
1/2019Studies on the Mechanism of Glutamate Metabolism in NTG-Induced Migraine Rats Treated with DCXF.
1/2016Determination of the levels of two types of neurotransmitter and the anti-migraine effects of different dose-ratios of Ligusticum chuanxiong and Gastrodia elata.
6/2015Effects of Ligusticum chuanxiong and Gastrodia elata on blood-brain barrier permeability in migraine rats.
8/2012Pharmacokinetics, tissue distribution and metabolism of senkyunolide I, a major bioactive component in Ligusticum chuanxiong Hort. (Umbelliferae).
6/2012Comparative pharmacokinetics of senkyunolide I in a rat model of migraine versus normal controls.
2/2011Effect and mechanism of senkyunolide I as an anti-migraine compound from Ligusticum chuanxiong.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao Lin Research Topics

Disease

51Neoplasms (Cancer)
03/2024 - 06/2003
22Inflammation (Inflammations)
10/2023 - 10/2013
13Hypoxia (Hypoxemia)
01/2023 - 04/2012
11Osteoporosis
04/2024 - 10/2013
11Breast Neoplasms (Breast Cancer)
01/2023 - 01/2014
8Hepatocellular Carcinoma (Hepatoma)
02/2024 - 10/2002
8Lung Neoplasms (Lung Cancer)
02/2024 - 11/2012
8Infections
07/2023 - 01/2017
8Wounds and Injuries (Trauma)
02/2023 - 01/2017
8Migraine Disorders (Migraine)
01/2021 - 02/2011
8Carcinoma (Carcinomatosis)
01/2020 - 06/2007
7Carcinogenesis
03/2024 - 10/2013
7Ischemia
10/2022 - 01/2010
7Fibrosis (Cirrhosis)
01/2022 - 01/2017
6Atherosclerosis
11/2023 - 01/2018
6Osteoarthritis
08/2023 - 01/2015
6Cardiovascular Diseases (Cardiovascular Disease)
04/2023 - 01/2010
6Arthritis (Polyarthritis)
04/2021 - 12/2014
5Body Weight (Weight, Body)
02/2024 - 05/2020
5Hepatitis B
01/2024 - 04/2021
5Ischemic Stroke
08/2023 - 01/2019
5Vascular Calcification
07/2023 - 09/2019
5Neoplasm Metastasis (Metastasis)
03/2023 - 05/2009
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2021 - 09/2015
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2015 - 01/2009
4Chronic Hepatitis B
05/2023 - 01/2021
4Adenocarcinoma of Lung
03/2023 - 11/2012
4Hyperlipidemias (Hyperlipidemia)
01/2023 - 01/2018
4Major Depressive Disorder (Major Depressive Disorders)
01/2023 - 11/2020
4Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2023 - 01/2020
4Infarction (Infarctions)
10/2022 - 11/2016
4Schizophrenia (Dementia Praecox)
01/2021 - 01/2017
4Hyperglycemia
01/2021 - 01/2019
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 01/2015
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
07/2019 - 01/2018
4AIDS-Related Complex (ARC)
10/2018 - 05/2013
3Obesity
04/2024 - 01/2021
3Hypertension (High Blood Pressure)
03/2024 - 01/2021
3Esophageal Squamous Cell Carcinoma
03/2024 - 10/2016
3Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 03/2004
3Type 2 Diabetes Mellitus (MODY)
12/2023 - 03/2015
3Myopia
01/2023 - 01/2016
3Leukemia
11/2022 - 10/2013
3Tobacco Use Disorder (Nicotine Dependence)
01/2022 - 01/2020
3Fatty Liver
01/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
01/2024 - 10/2013
17Biomarkers (Surrogate Marker)IBA
08/2023 - 01/2015
15Glucose (Dextrose)FDA LinkGeneric
10/2023 - 01/2010
11MicroRNAs (MicroRNA)IBA
04/2024 - 01/2016
8CytokinesIBA
03/2023 - 11/2016
6Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2024 - 01/2021
6Lipoproteins (Lipoprotein)IBA
11/2023 - 01/2018
6Histones (Histone)IBA
01/2023 - 04/2011
6Messenger RNA (mRNA)IBA
11/2022 - 01/2018
6LipidsIBA
09/2021 - 01/2018
6AntioxidantsIBA
03/2017 - 12/2014
5Particulate MatterIBA
03/2024 - 10/2017
5Fatty Acids (Saturated Fatty Acids)IBA
03/2024 - 01/2019
5CholesterolIBA
11/2023 - 01/2018
5InflammasomesIBA
08/2023 - 01/2018
5Oxygen (Dioxygen)IBA
01/2023 - 01/2010
5Interleukin-6 (Interleukin 6)IBA
11/2022 - 01/2021
5LDL Receptors (LDL Receptor)IBA
09/2021 - 01/2018
5Monoamine Oxidase (MAO)IBA
10/2018 - 05/2013
5AlloysIBA
10/2018 - 05/2013
5Polysaccharides (Glycans)IBA
11/2016 - 01/2009
4Long Noncoding RNAIBA
03/2024 - 01/2018
4Lysine (L-Lysine)FDA Link
02/2024 - 04/2011
4InterferonsIBA
11/2023 - 04/2021
4Phosphates (Orthophosphate)IBA
01/2023 - 01/2018
4RNA (Ribonucleic Acid)IBA
01/2023 - 01/2022
4Pattern Recognition ReceptorsIBA
01/2023 - 01/2020
4CollagenIBA
01/2022 - 01/2016
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 10/2002
4Gallic AcidIBA
12/2016 - 12/2014
3CateninsIBA
03/2024 - 08/2016
3Therapeutic UsesIBA
02/2024 - 01/2020
3Small Interfering RNA (siRNA)IBA
02/2024 - 01/2018
3oxidized low density lipoproteinIBA
11/2023 - 01/2018
3LDL CholesterolIBA
11/2023 - 01/2019
3Triglycerides (Triacylglycerol)IBA
10/2023 - 01/2019
3Peptides (Polypeptides)IBA
01/2023 - 01/2019
3EnzymesIBA
01/2023 - 02/2013
3Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 01/2017
3NF-kappa B (NF-kB)IBA
01/2023 - 05/2009
3Antiviral Agents (Antivirals)IBA
01/2022 - 04/2021
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2012
3Surface Antigens (Surface Antigen)IBA
01/2022 - 04/2021
3Immunoglobulins (Immunoglobulin)IBA
06/2021 - 01/2021
3Neurotransmitter Agents (Neurotransmitter)IBA
01/2021 - 02/2011
3Insulin (Novolin)FDA Link
01/2021 - 03/2015
3AntigensIBA
01/2021 - 02/2013

Therapy/Procedure

31Therapeutics
11/2023 - 12/2004
12Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2023 - 01/2010
9Radiotherapy
01/2023 - 12/2004
8Drug Therapy (Chemotherapy)
11/2022 - 09/2015
4Precision Medicine
03/2020 - 12/2018
3Injections
07/2023 - 01/2019
3Mastectomy (Mammectomy)
01/2023 - 01/2019
3Debridement
01/2023 - 05/2019